Abstract
In The Lancet, Gloria Ikilezi and colleagues1 estimated annual spending on immunisation by governments, households, and donors for 135 low-income and middle-income countries (LMICs) between 2000 and 2017. To do so, the authors collated financial data from a variety of sources, including National Health Accounts, vaccine-specific financial reporting and budgeting, and donor records, and used financial modelling to reconcile inconsistencies and gaps in the data, reporting outcomes in standardised cost categories.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
